Breakthroughs in the treatment and prevention of Clostridium difficile infection | Nature Reviews Gastroenterology & Hepatology
Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Pfizer's seeks silver lining in failed C. diff vaccine trial | pharmaphorum
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial - The Lancet Infectious Diseases
Old C. difficile Vaccine Candidate MVX02 | matrivax
New Clostridioides difficile vaccine on the horizon • healthcare-in-europe.com
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile | BMC Infectious Diseases | Full Text
Chasing Sanofi, Pfizer tees up phase 3 trials for C. diff vaccine | Fierce Biotech
Pathogens | Free Full-Text | Non-Toxin-Based Clostridioides difficile Vaccination Approaches
C. difficile Vaccine Candidate MVX02 | matrivax
Frontiers | Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile
Frontiers | Targeting Clostridium difficile Surface Components to Develop Immunotherapeutic Strategies Against Clostridium difficile Infection
C. diff vaccine trial strikes one blow in bigger bug battle - UCHealth Today
Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection | Microbiology Spectrum
Clostridium difficile Infection Prevention: Biotherapeutics, Immunologics, and Vaccines - Dale N Gerding - Discovery Medicine
Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections - ScienceDirect
Frontiers in antibiotic alternatives for Clostridioides difficile infection
Frontiers | Host Immune Responses to Clostridioides difficile: Toxins and Beyond
Percentages of participants who achieved prespecified levels of toxin... | Download Scientific Diagram
C. Diff Vaccine (high risk patients) – J. Lewis Research, Inc.
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes | NEJM
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Cytotoxic activity of purified toxins from prevalent C. difficile... | Download Table
